top of page

Introducing Vesta

The next generation CIED envelope.


Antibiotic Eluting



Vesta is designed for Electrophysiologists and Cardiologists

Disclaimer: medical device under development. 

Vesta is a bioresorbable, antibiotic eluting envelope for Cardiac Implantable Electronic Devices (CIEDs): Pacemakers, Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapies (CRTs). Vesta holds and stabilizes the CIED while providing sustained, localized elution of antibiotics.

Infection in CIEDs

Infection in cardiac implantable electronic devices (CIEDs), such as pacemakers and implantable cardioverter-defibrillators, can occur due to various factors, including surgical site contamination and hematogenous microbial spread.

1 in 18

Real-world infection rate in

high-risk CIED patients.

When left untreated, these infections can lead to serious complications, such as device malfunction, sepsis, or even death. 

CIED infections are severe clinical conditions, leading to device removal, hospitalization, and even mortality.

4 in 5

Patients with infected CIED untreated or undetected.



55-150k $


Days, average time in hospital

Average compound treatment costs 

Medical guidelines recommend full extraction of the CIED in case of infection 

The efficacy, safety and cost-benefits of antibiotic eluting envelopes in reducing local and systemic infections in CIEDs has been demonstrated in large-scale randomized clinical trials     , as well as in real-world evidence data.


Antibiotic eluting envelopes are the consensus choice to reduce infection risk in CIED patients. 


We combine high-tech material, process and chemical engineering to achieve the medical goals desired by the clinical community, with human-centered design to maximize end-user experience in the operating room.

Biocompatible resorbable materials

All Vesta materials are FDA-approved for implantable medical devices. They meet the highest biocompatibility standards and fully resorb in the body after implantation. Their mechanical and chemical properties can be precisely tuned to meet clinical needs.

Controlled release of active compounds

Our advanced technology allows precise tuning of antibiotic and drug elution. We ensure accurate dosage and controlled, sustained release to meet any medical need. The amount, type, and release dynamics of compounds can be customized to clinical requirements.

Human-centered design

We use state-of-the-art designs to prioritize doctor experience and patient comfort. Vesta is easily deployable, with just a 1-minute preparation time. Softness, form-factor, and ease of implantation have been central to our design.

Next steps: the solution of choice for prevention



Cardiac Implantable Electronic Devices (CIEDs)



Deep Brain & Spinal Cord Stimulation, Pain Management 



Bone Fixation Plates


Reconstructive Surgery

Breast Reconstruction


Surgical Meshes

Hernia, Pelvic Prolapse


Ventricular Assist Devices

Bridge to transplant

Want to know more?
Have an idea you would like to discuss?


Contact us

Message sent. Thanks!


1. Ziacchi et al, Europace 2023, doi: 10.1093/europace/euad224

2. Pokorney et al, JAMA Cardiol 2023, doi: 10.1001/jamacardio.2023.3379

3. Blomström-Lundqvist et al, Europace 2020, doi: 10.1093/europace/euz246

4. Wilkoff et al, AHA Scientific Sessions 2019, Su3088

5. Burnhope et al, J Med Econ. 2019,

6. Ahsan et al, Europace 2014, doi: 10.1093/europace/euu126

7. Egea et al, EHRA Congress Poster Presentation 2018

8. Shariff et al, J Cardiovasc Electrophysiol 2015, doi: 10.1111/jce.12684

9. Wilkoff et al, AHA Scientific Sessions 2019, Su3088

10. Sohail et al, Arch Intern Med 2011, doi: 10.1001/archinternmed.2011.441

11. Lopatto et al, ACC Presentation 2017

12. Sohail et al, Circ Arrhythm Electrophysiol 2016, doi: 10.1161/CIRCEP.116.003929

13. Greenspon et al, Pacing Clin Electrophysiol 2018, doi: 10.1111/pace.13300

14. Eby et al, J Med Econ 2020, doi: 10.1080/13696998.2020.1751649

15. Medtronic Inc website

16. Tarakji et al, N Engl J Med 2019, doi: 10.1056/NEJMoa1901111

17. Krahn et al, J Am Coll Cardiol 2018, doi: 10.1016/j.jacc.2018.09.068 

bottom of page